FOTIVDA vs VOTRIENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. FOTIVDA and VOTRIENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	FOTIVDA	VOTRIENT
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TIVOZANIB HYDROCHLORIDE	PAZOPANIB HYDROCHLORIDE
Manufacturer	Aveo Pharms	Novartis
Dosage forms	Capsule	Tablet
Drug class	—	—
Boxed warning	None	Boxed warning
Treats	Renal Cell Carcinoma	Renal Cell Carcinoma, Soft Tissue Neoplasms

fotivda votrient

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

TIVOZANIB HYDROCHLORIDE

PAZOPANIB HYDROCHLORIDE

Manufacturer

Aveo Pharms

Novartis

Dosage forms

Capsule

Tablet

Drug class

—

Boxed warning

None

Boxed warning

Treats

Renal Cell Carcinoma

Renal Cell Carcinoma, Soft Tissue Neoplasms

Frequently asked questions

What is the difference between Fotivda and Votrient?

Fotivda contains Tivozanib Hydrochloride, while Votrient contains Pazopanib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.